Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes.
Int J Radiat Oncol Biol Phys
; 108(4): 979-986, 2020 11 15.
Article
in En
| MEDLINE
| ID: mdl-32599030
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Chemoradiotherapy
/
Bevacizumab
/
Antineoplastic Agents, Immunological
/
Glioma
/
Neoplasm Recurrence, Local
Type of study:
Diagnostic_studies
/
Observational_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Int J Radiat Oncol Biol Phys
Year:
2020
Document type:
Article